The stability and fate of a spliced intron from vertebrate cells

RNA

Volumn 5, Issue 2, 1999, Pages 206-220

  Clement, Jade Q ^a   Qian, Lian ^a   Kaplinsky, Nickalus ^a   Wilkinson, Miles F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Actinomycin D; In vivo branchpoint; Intron half life; Intron lariat; Subcellular fractionation; T cell receptor; Tetracycline regulated promoter

Indexed keywords

DACTINOMYCIN; MESSENGER RNA PRECURSOR; T LYMPHOCYTE RECEPTOR; TETRACYCLINE;

ARTICLE; CELL FRACTIONATION; CELL NUCLEUS; CONTROLLED STUDY; HALF LIFE TIME; HELA CELL; HUMAN; HUMAN CELL; INTRON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING; SUCROSE GRADIENT; VERTEBRATE;

ANIMALS; DACTINOMYCIN; HELA CELLS; HUMANS; INTRONS; KINETICS; MICE; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS (GENETICS); RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER; TETRACYCLINE; TRANSCRIPTION, GENETIC; TRANSFECTION;

ADENOVIRIDAE; EUKARYOTA; VERTEBRATA;

EID: 0033064680     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1355838299981190     Document Type: Article

References (71)

1. Adema GJ, Bovenberg RAL, Jansz HS, Baas PD. 1988. Unusual branch point selection involved in splicing of the alternatively processed calcitonin/CGRP-1 pre-mRNA. Nucleic Acids Res 16:9513-9526.
2. Arenas J, Hurwitz J. 1987. Purification of a RNA debranching activity from HeLa cells. J Biol Chem 262:4274-4279.
3. Belasco JG. 1993. mRNA degradation in prokaryotic cells: An overview. In: Belasco JG, Brawerman G, eds. Control of messenger RNA stability. San Diego: Academic Press, pp 3-12.
4. Belasco JG, Brawerman G. 1993. Experimental approaches to the study of mRNA decay. In: Belasco JG, Brawerman G, eds. Control of messenger RNA stability. San Diego: Academic Press, pp 475-493.
5. Berezney R, Jeon KW. 1995. Nuclear matrix: Structural and functional organization. San Diego: Academic Press.
6. Berman SA, Bursztajn S, Bowen B, Gilbert W. 1990. Localization of an acetylcholine receptor intron to the nuclear membrane. Science 247:212-214.
7. Blencowe BJ, Issner R, Kim J, McCaw P, Sharp PA. 1995. New proteins related to the Ser-Arg family of splicing factors. RNA 1:852-865.
8. Brown AJP, Purvis IJ, Santiago TC, Bettany AJE, Loughlin L, Moore J. 1988. Messenger RNA degradation in Saccharomyces cerevisiae. Gene 72:151-160.
9. Carter MS, Doskow J, Morris P, Li S, Nhim RP, Sandstedt S, Wilkinson MF. 1995. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem 270:28995-29003.
10. Carter MS, Li S, Wilkinson MF. 1996. A splicing-dependent regulatory mechanism that detects translation signals. EMBO J 15:5965-5975.
11. Caruccio N, Ross J. 1994. Purification of a human polyribosome-associated 3′ to 5′ exoribonuclease. J Biol Chem 269:31814-31821.
12. Chan WKY, Belfort G, Belfort M. 1988. Stability of group I intron RNA in Escherichia coli and its potential application in a novel expression. Gene 75:295-304.
13. Chapman KB, Boeke JD. 1991. Isolation and characterization of the gene encoding yeast debranching enzyme. Cell 65:483-492.
14. Coleclough C, Wood D. 1984. Introns excised from immunoglobulin pre-mRNA exist as discrete species. Mol Cell Biol 4:2017-2022.
15. Cooke C, Alwine JC. 1996. The cap and the 3′ splice site similarly affect polyadenylation efficiency. Mol Cell Biol 16:2579-2584.
16. Curtis PJ, Mantel N, Weissmann C. 1977. Characterization and kinetics of synthesis of 15S β-globin RNA, a putative precursor of β-globin mRNA. Cold Spring Harbor Symp Quant Biol 42:971-984.
17. Dani C, Blanchard JM, Piechaczyk M, Sabouty SE, Marty L, Jeanteur P. 1984. Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci USA 81:7046-7050.
18. Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription inhibition by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
19. Dubois M-F, Nguyen VT, Bellier S, Bensaude O. 1994. Inhibitors of transcription such as 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit. J Biol Chem 269:13331-13336.
20. Eperon IC, Krainer AR. 1994. Splicing of mRNA precursors in mammalian cells. In: Higgins SJ, Hames BD, eds., RNA processing: A practical approach, Vol. 1. Oxford: IRL Press, pp 57-101.
21. Farrell MJ, Dobson AT, Feldman LT. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci USA 88:790-794.
22. Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
23. Grabowski, PJ. 1994. Characterization of RNA. In: Higgins SJ, Hames BD, eds. RNA processing: A practical approach, Vol 1. Oxford: IRL Press, pp 31-55.
24. Green MR. 1991. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Ann Rev Cell Biol 7:559-599.
25. Hargrove JL, Schmidt FH. 1989. The role of mRNA and protein stability in gene expression. FASEB J 3:2360-2370.
26. Hartmuth K, Barta A. 1988. Unusual branch point selection in processing of human growth hormone pre-mRNA. Mol Cell Biol 8:2011-2020.
27. Hedrick SM, Nielsen EA, Kavaler J, Cohen DI, Davis MM. 1984. Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature 308:153-156.
28. Horning H, Aebi M, Weissmann C. 1986. Effect of mutations at the lariat branch acceptor site on β-globin pre-mRNA splicing in vitro. Nature 324:589-591.
29. Izaurralde E, Adam S. 1998. Transport of macromolecules between the nucleus and the cytoplasm. RNA 4:351-364.
30. Jacquier A, Rosbash M. 1986. RNA splicing and intron turnover are greatly diminished by a mutant yeast branchpoint. Proc Natl Acad Sci USA 83:5835-5839.
31. Jarmolowski A, Boelens WC, Izaurralde E, Mattaj I. 1994. Nuclear export of different classes of RNA is mediated by specific factors. J Cell Biol 124:627-635.
32. Keller W. 1984. The RNA lariat: A new ring to the splicing of mRNA precursors. Cell 39:423-425.
33. Keohavong P, Gattoni R, Schmitt P, Stévenin J. 1986. The different intron 2 species excised in vivo from the E2A pre-mRNA of adenovirus-2: An approach to analyze alternative splicing. Nucleic Acids Res 14:5207-5227.
34. Kopczynski CC, Muskavitch MA. 1992. Introns excised from the Delta primary transcript are localized near sites of Delta transcription. J Cell Biol 119:503-512.
35. Kriegler M. 1990. Gene transfer and expression, a laboratory manual. New York: Stockton Press.
36. Leppard KN, Shenk T. 1989. The adenovirus E1B 55 kd protein influences mRNA transport via an intranuclear effect on RNA metabolism. EMBO J 8:2329-2336.
37. Michaeli T Pan Z-Q, Prives C. 1988. An excised SV40 intron accumulates and is stable in Xenopus laevis oocytes. Genes & Dev 2:1012-1020.
38. Moore MJ, Query CC, Sharp PA. 1993. Splicing of precursors to mRNAs by the spliceosome. In: Gesteland RF, Atkins JF, eds. The RNA world. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, pp 303-357.
39. Müllner EW, Kühn LC. 1988. A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53:815-825.
40. Nam K, Hudson RHE, Chapman KB, Ganeshan K, Damha MJ, Boeke JD. 1994. Yeast lariat debranching enzymes. J Biol Chem 269:20613-20621.
41. Nam K, Lee G, Trambley J, Devine SE, Boeke JD. 1997. Severe growth defect in Schizosaccharomyces pombe mutant defective in intron lariat degradation. Mol Cell Biol 17:809-818.
42. Naora H, Deacon NJ. 1982. Relationship between the total size of exons and introns in protein-coding genes of higher eukaryotes. Proc Natl Acad Sci USA 79:6196-6200.
43. Nesic D, Cheng J, Maquat LE. 1993. Sequences within the last intron function in RNA 3′ end formation in cultured cells. Mol Cell Biol 13:3359-3369.
44. Nesic D, Maquat LE. 1994. Upstream introns influence the efficiency of final intron removal and RNA 3′-end formation. Genes & Dev 8:363-375.
45. Nickerson JA, Krochmalnic G, Wan KM, Penman S. 1989. Chromatin architecture and nuclear RNA. Proc Natl Acad Sci USA 86:177-181.
46. Nicosia M, Zabolotny JM, Lirette RP, Fraser NW. 1994. The HSV-12-kb latency-associated transcript is found in the cytoplasm comigrating with ribosomal subunits during productive infection. Virology 204:717-728.
47. Nigg EA. 1997. Nucleocytoplasmic transport: Signals, mechanisms and regulation. Nature 386:779-787.
48. Niwa M, Berget SM. 1991. Mutation of the AAUAAA polyadenylation signal depresses in vitro splicing of proximal but not distal introns. Genes & Dev 5:2086-2095.
49. Niwa M, Rose SD, Berget SM. 1990. In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes & Dev 4:1552-1559.
50. Padgett RA, Konarska MM, Aebi M, Hornig H, Weissmann C, Sharp PA. 1985. Nonconsensus branch-site sequences in the in vitro splicing of transcripts of mutant rabbit β-globin genes. Proc Natl Acad Sci USA 82:8349-8353.
51. Padgett RA, Konarska MM, Grabowski PJ, Hardy SF, Sharp PA. 1984. Lariat RNA's as intermediates and products in the splicing messenger RNA precursors. Science 225:898-903.
52. Peltz SW, Jacobson A. 1993. mRNA turnover in Saccharomyces cerevisiae. In: Belasco JG, Brawerman G, eds. Control of messenger RNA stability. San Diego: Academic Press, pp 291-328.
53. Qian L, Theodor L, Carter M, Vu MN, Sasaki AW, Wilkinson MF. 1993a. T cell receptor-β mRNA splicing: Regulation of unusual splicing intermediates. Mol Cell Biol 13:1686-1696.
54. Qian L, Vu MN, Carter MS, Doskow J, Wilkinson MF. 1993b. T cell receptor-β mRNA splicing during thymic maturation in vivo and in an inducible T cell clone in vitro. J Immunol 151:6801-6814.
55. Qian L, Vu MN, Carter M, Wilkinson MF. 1992. A spliced intron accumulates as a lariat in the nucleus of T cells. Nucleic Acids Res 20:5345-5350.
56. Reed R, Maniatis T. 1985. Intron sequences involved in lariat formation during pre-mRNA splicing. Cell 41:95-105.
57. Ross J. 1995. mRNA stability in mammalian cells. Micro Rev 59:423-450.
58. Ruskin B, Green MR. 1985. An RNA processing activity that debranches RNA lariats. Science 229:135-140.
59. Ruskin B, Krainer AR, Maniatis T, Green MR. 1984. Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38:317-331.
60. Seiser C, Posch M, Thompson N, Kühn LC. 1995. Effect of transcription inhibitors on the iron-dependent degradation of transferrin receptor mRNA. J Biol Chem 270:29400-29406
61. Sharp PA. 1994. Split genes and RNA splicing. Cell 77:805-815.
62. Sharp PA, Konarska MM, Grabowski PJ, Lamond Al, Marciniak R, Seiler SR. 1987. Splicing of messenger RNA precursors. Cold Spring Harbor Symp Quant Biol 52:277-285.
63. Sperling R, Sperling J, Levine AD, Spann P, Stark GR, Kornberg RD. 1985. Abundant nuclear ribonucleoprotein form of CAD RNA. Mol Cell Biol 5:569-575.
64. Tamm I, Sehgal PB. 1978. Halobenzimidazole ribosides and RNA synthesis of cells and viruses. Adv Virus Res 22:187-258.
65. Wang D, Hawley DK. 1993. Identification of a 3′-5′ exonuclease activity associated with human RNA polymerase II. Proc Natl Acad Sci USA 90:843-847.
66. Wassarman DA, Steitz JA. 1992. Interactions of small nuclear RNA's with precursor messenger RNA during in vitro splicing. Science 257:1918-1925.
67. Wijgerde M, Grosveld F, Fraser P. 1995. Transcription complex stability and chromatin dynamics in vivo. Nature 377:209-213.
68. Wilkinson MF. 1991. Purification of RNA. In: Brown TA, ed. Basic molecular biology: A practical approach. Oxford: IRL Press, pp 69-87.
69. Zeitlin S, Efstratiadis A. 1984. In vivo splicing products of the rabbit β-globin pre-mRNA. Cell 39:589-602.
70. Zhuang Y, Goldstein AM, Weiner AM. 1989. UACUAAC is the preferred branch site for mammalian mRNA splicing. Proc Natl Acad Sci USA 86:2752-2756.
71. Zillman M, Zapp ML, Berget SM. 1988. Gel electrophoretic isolation of splicing complexes containing U1 nuclear ribonucleoprotein particles. Mol Cell Biol 8:814-821.